Recon: $26B Opioids lawsuit deal imminent; Amylyx closes $135M ALS financing deal

Advertising, Promotion and LabelingAPIsAsiaBiologics/ biosimilars/ vaccinesBiotechnologyClinical TrialsCombination products/companion diagnosticsDiagnostics/IVDsEthicsEuropeGlobalHealth Authority meeting and communication strategyMedical DevicesNorth AmericaNutritional/Natural HealthOTCOtherPharmaceuticalsProduct LifecycleProfessional Development/TrainingRegulatory Intelligence/PolicyResearch, Design and Development